Pasithea Therapeutics Ownership | Who Owns Pasithea Therapeutics?


OverviewFinancialsChart

Pasithea Therapeutics Ownership Summary


Pasithea Therapeutics is owned by 0.99% institutional investors, and 99.01% retail investors. AdvisorShares Psychedelics ETF is the top mutual fund, with 1.98% of its assets in Pasithea Therapeutics shares.

KTTA Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockPasithea Therapeutics0.99%-99.01%
SectorHealthcare Stocks 57.39%9.93%32.68%
IndustryBiotech Stocks 68.48%9.65%21.87%

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 20238-33.33%248,808-2.59%-103.48%3-57.14%2-33.33%
Sep 30, 202312-255,417-32.44%-46.49%740.00%3-
Jun 30, 202312-378,085-1.83%166.46%525.00%3-
Mar 31, 2023129.09%385,124-39.00%123.62%4-50.00%350.00%
Dec 31, 20221137.50%631,393-22.91%226.27%8100.00%2100.00%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
AdvisorShares Psychedelics ETF53.55K1.98%-
Northern Trust Extended Eq Market Idx1.67K0.13%-
Fidelity Extended Market Index2.96K0.11%-
NT Ext Equity Mkt Idx Fd - L1.67K0.06%-
Fidelity Series Total Market Index880.000.03%-
NT Ext Eq Mkt Indx Fd DC Lend T3399.000.03%399.00
NT Ext Eq Mkt Indx Fd DC Lend T4399.000.03%399.00
NT Ext Eq Mkt Indx Fd DC Lending Tier 5402.000.01%3.00
Spartan Total Market Index Pool G229.000.01%-
Spartan Total Market Index Pool E229.000.01%-

Insider Transactions Trends


DateBuySell
2024 Q2--
2024 Q1--
2023 Q21-
2022 Q41-
2022 Q313-

KTTA Ownership FAQ


Who Owns Pasithea Therapeutics?

Pasithea Therapeutics shareholders are primarily institutional investors at 0.99%, followed by 0% insiders and 0% retail investors. The average institutional ownership in Pasithea Therapeutics's industry, Biotech Stocks , is 68.48%, which Pasithea Therapeutics falls below.

Does Blackrock own Pasithea Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Pasithea Therapeutics.

Who is the top mutual fund holder of Pasithea Therapeutics shares?

AdvisorShares Psychedelics ETF is the top mutual fund holder of Pasithea Therapeutics shares, with 1.98% of its total shares outstanding invested in 53.55K Pasithea Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools